Seattle Children's is facing violations after mold investigation

Cited deficiencies include the failure to properly maintain air filtering systems that fed to operating rooms


Seattle Children's hospital is working to address violations found by the Washington State Department of Health (DOH) and the Centers for Medicare and Medicaid Services (CMS) amid an investigation of mold, according to an article on the K5 News website.

One patient died and five others were infected in the past two years after Aspergillus mold was found in the operating rooms.  

As a result of the investigation, DOH and CMS provided the hospital with statements of deficiencies.

Cited deficiencies include the failure to properly maintain air filtering systems that fed to operating rooms and the failure to inspect or calibrate air flow monitoring equipment to make sure it worked.

Read the article.



July 15, 2019


Topic Area: Infection Control


Recent Posts

The Debate on Laundering Microfibers in Healthcare

Should microfibers be single-use or reusable? Researchers have opinions on both.


Construction Begins for New Cancer Center at OhioHealth's Administrative Campus

The project’s completion date is estimated for late 2028.


Sutter Health and Alina Health to Form 39-Hospital System

The organizations anticipate closing by the end of 2026, pending regulatory approval.


IAQ and Infection Mitigation in Aging Facilities

Challenges can contribute to elevated risks related to patient safety, staff comfort and retention, and heightened regulatory and accreditation scrutiny.


Preventing Pests: Effective Measures in Healthcare Facilities

How integrated pest management can protect patient health.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.